Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0000945234-09-000105
Filing Date
2009-04-08
Accepted
2009-04-08 11:16:25
Documents
1
Effectiveness Date
2009-04-08

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 o54651sv8pos.htm S-8 POS 13743
  Complete submission text file 0000945234-09-000105.txt   15250
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-136393 | Film No.: 09739078
SIC: 2835 In Vitro & In Vivo Diagnostic Substances